Axtria Blogs

Value & Outcomes Based Pharma Commercial Modeling

How the Importation of Price Controls on Medicare Part B and D Drugs Affect Pharma Commercial Operations
How Should Pharma Companies Prepare for Future Price Controls

How Should Pharma Companies Prepare for Future Price Controls?

Many in the pharma industry currently fear that the broad use of price controls, once thought of as being theoretical and a remote possibility, is now an inevitability. This author has previously noted in articles published on the Axtria Research Hub that the imposition of price controls represent an existential threat to the industry. The political forces that once shielded the industry from the imposition of direct price controls for federal reimbursement on programs like Medicare have been severely weakened. The imposition of such federal program controls will effectively spillover into private insurance markets.

Read More

Let Us Show You What Axtria’s 

Solutions Can Do For You